Dr. Xu is a biostatistician and Clinician Scientist at the Princess Margaret Cancer Center, and an Associate Professor in Biostatistics at the University of Toronto's Dalla Lana School of Public Health. As Principal-Investigator or co-Investigator, he has been involved in study design, data administration, statistical modeling development and data analysis on different clinical research and human genetic studies. He has published over 250 peer-reviewed papers in the field of statistics, bioinformatics, medical science and human genetics.
Dr. Xu’s research interests focus on clinical trial design and methodology, biostatistics and bioinformatics methodology, statistical genetics, and cancer clinical and translational research.
Support Care Cancer. 2019 Nov 28;:
Mapping the University of Washington Quality of life questionnaire onto EQ-5D and HUI-3 indices in patients with head and neck cancer.
Head Neck. 2019 Nov 24;:
Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.
Radiother Oncol. 2019 Nov 08;144:13-22
Elife. 2019 Oct 28;8:
Real-world health utility scores and toxicities to tyrosine kinase inhibitors in epidermal growth factor receptor mutated advanced non-small cell lung cancer.
Cancer Med. 2019 Oct 24;:
Evaluation of Older Age and Frailty as Factors Associated With Depression and Postoperative Decision Regret in Patients Undergoing Major Head and Neck Surgery.
JAMA Otolaryngol Head Neck Surg. 2019 Oct 17;:
Int J Radiat Oncol Biol Phys. 2019 Sep 27;:
Treatment outcomes in oropharynx cancer patients who did not complete planned curative radiotherapy.
Oral Oncol. 2019 Oct;97:124-130
Am J Clin Oncol. 2019 Oct;42(10):777-782
Clinician Scientist, Princess Margaret Cancer Centre
Principal Biostatistician, Princess Margaret Cancer Center, UHN
Associate Professor, Dalla Lana School of Public Health, University of Toronto